Home-Logo
left-arrow
person

Dr Chloe Maxwell-Smith

Senior Lecturer
Curtin School of Population Health

Cancer Survivorship

Dr Chloé Maxwell-Smith is a psycho-oncology researcher at the Curtin Medical Research Institute. She is Chair of the Psycho-Oncology Cooperative Research Group (PoCoG) Cancer Prevention Group. Her research focuses on understanding and addressing barriers to health behaviours among people affected by cancer, across cancer screening, detection, survivorship, toxicities, and access to support. She has led and contributed to clinical trials and mixed-methods studies aimed at improving health outcomes and quality of life for cancer survivors, including those in regional and remote communities. Dr Maxwell-Smith works closely with clinical and community partners, including Cancer Council WA, to translate research into practice and inform policy and program delivery.


About

Dr Chloé Maxwell-Smith work focuses on understanding how people affected by cancer experience care, access support, and engage in behaviours that promote wellbeing.


Her research spans prevention, early detection, and survivorship, using mixed methods to explore the psychological, social, and systemic factors that shape outcomes. With a strong emphasis on regional, underserved, and diverse communities, she designs and evaluates practical, scalable interventions that improve access to care, quality of support, and long term health behaviours.


Working closely with clinical and community partners, including Cancer Council WA, Dr Chloé Maxwell-Smith ensures her research is grounded in lived experience and translated into real world impact. Based at Curtin University, she leads a multidisciplinary programme of work aimed at improving both the experience and wellbeing of people affected by cancer.

  • Chair, PoCoG Cancer Prevention Special Interest Group.
  • Member, PoCoG Scientific Advisory Committee.
  • Excutive Committee, Australasian Society for Behavioural Health and Medicine.
  • Multinational Association of Supportive Care in Cancer (MASCC), including Neurological Complications (with Cancer-Related Cognitive Impairment focus), Survivorship, and Onco-Dermatology study groups.
  • Clinical Oncology Society of Australia (COSA), including AYA, Breast Cancer, Cancer Biology, Cancer Care Coordination, Cancer Genetics, Clinical Trials & Research Professionals, Epidemiology, Exercise & Cancer, Gastrointestinal Cancer, Gynaecological Oncology, Neuro-Oncology, Psycho-Oncology, Rare Cancers, Regional & Rural Oncology, and Survivorship & Implementation groups.
  • Psycho-Oncology Cooperative Research Group (PoCoG), including End of Life Care, Fear of Recurrence, Cancer-Related Cognitive Impairtment, and Cancer Prevention groups.
  • Cooperative Trials Group for Neuro-Oncology (COGNO).
  • Breast Cancer Trials, Australia.
  • Australia & New Zealand Gynaecological Oncology Group (ANZGOG).
  • Curtin University Early Career Researcher of the Year - 2025
  • Celebration of Innovation in Learning and Teaching Presentation Award - 2025
  • Leigh Smith award for outstanding contribution to the Discipline of Psychology - 2023
  • Best Professional Presentation Award, Australasian Society for Behavioural Health and Medicine - 2023
  • Citizen award for contribution to the School of Population Health - 2022

Research Focus

Dr Chloé Maxwell-Smith explores how people affected by cancer experience care, access health supports, and engage in behaviours that promote wellbeing. Her research spans survivorship, early detection, and prevention, using mixed methods to understand the psychological, social, and systemic factors that shape experiences and outcomes.


She designs and evaluates interventions and programmes aimed at improving access to care, enhancing the quality of support, and fostering sustainable health behaviours. Her work places particular emphasis on regional, underserved, and diverse communities.




By partnering with health services, cancer organisations, and policy makers, Dr Chloé Maxwell-Smith ensures that her research remains practical, inclusive, and actionable.

Research Team

Kat McKenzie

Sessional Academic

Hayley Breare

Casual Academic

Suren Dorjsuren

Alejandro Dominguez Garcia

PhD Student

Samuel Antonio

PhD Student

Shantelle Smith

PhD Student

Publications

ABSTRACT

Adults undergoing treatment for breast cancer (BC) are advised to participate in regular exercise. However, many struggle to exercise consistently due to the side effects of systemic treatments including nausea, fatigue, and pain. In adults with newly diagnosed BC, this trial will evaluate the effectiveness of a new exercise intervention, compared with usual care, on outcomes including health-related quality of life (HRQoL).

Materials
This randomised controlled trial is underway at an Australian tertiary hospital. The protocol was prospectively registered (Australian New Zealand Clinical Trials RegistryACTRN12623001168640p). Consenting adults with BC diagnosed within the prior six months, with planned chemotherapy and/or endocrine treatment will be randomised to an intervention or control group. Both groups receive usual physiotherapy and medical care. Those allocated to the intervention group are offered participation in the ‘SMART’ intervention (Self-determined, Monitored, Adaptable, Rehabilitation with Telehealth support). This involves 16-weeks of tailored, one-on-one physiotherapy-led exercise sessions including behaviour change techniques and the weekly goal of completing 150 minutes of aerobic exercise and two resistance training sessions. The primary outcome is HRQoL and secondary outcomes include physical assessments (muscle strength, exercise tolerance, body composition), healthcare utilisation, workplace absenteeism, mood, psychological determinants of behaviour change, chemotherapy completion rates and endocrine therapy completion. All outcomes are measured prior to randomisation and 16 weeks following randomisation. Additional assessments of all outcomes (excluding the physical assessment) occur at 8 weeks and 52 weeks following randomisation. Ongoing recruitment for two years from June 2024 is expected to achieve a sample size of 260. No results have been analysed.

Discussion
If the SMART intervention produces favourable change, this will support its adoption in clinical practice. A greater understanding of factors including BC stage, treatment type or variables relating to the exercise program, that influence the magnitude of exercise-induced change on HRQoL will inform future exercise programs.

Stinton, S., D. Edwick, C. Maxwell-Smith, N. Bear, L. J. Breen, A. D. Garcia, E. Dylke, K. Edwards, S. Lynch, A. Lloyd, and 5 more contributors. 2026. Evaluating the effect of the SMART intervention in people with recently diagnosed breast cancer who are being treated at a public tertiary hospital in Australia: protocol and statistical analysis plan for a single-blinded, single centre randomised controlled trial.Plos One 21 (1 January)
ABSTRACT
Health behaviours, such as physical activity, should be encouraged for primary and secondary prevention of non-communicable diseases. Community-based interventions delivered in non-clinical settings may serve to promote such health behaviours while capitalising on existing infrastructures. Such interventions can cater to the needs and preferences of specific community groups and hence have the potential to be accessible, appropriate, and appealing when designed and implemented appropriately. To design sustainable community-based interventions, it is important to outline the parameters of the intervention setting and establish and maintain stakeholder engagement. However, inequalities may exist whereby some effective interventions either do not reach or are less effective for population sub-groups. Thus, interventions may require adapting, tailoring, or targeting to reach across the social spectrum. The effectiveness and sustainability of community-based health behaviour change interventions require alignment between the target population, key stakeholders, and public health policy.


Mullan, B. A., C. Liddelow, H. Breare, and C. Maxwell-Smith. 2025. Health behaviour change interventions.In Routledge International Handbook of Health Psychology Global and Contemporary Issues, 495-507

Find a researcher

Search for researchers at Curtin MRI

Search by name

Search by area of research